NEWS

ABOUT TRANSPORT TECHNOLOGY & PIPELINE THERAPEUTIC MARKETS PARTNERS INVESTORS NEWS Press Releases Scientific Publications Event Listing Media Kit Glossary

Media Kit

pdf Download Corporate Fact Sheet

pdf Download Technology Fact Sheet

pdf Download Product Fact Sheet

Management Team Biographies

Art work/Product image/Captions

[Solovir_Rendering.tif]
Image: SoloVir™ Electrokinetic Transdermal System (ETS)
Caption: Transport’s SoloVir™ Electrokinetic Transdermal System (ETS) product targets herpes labialis, commonly called cold sores. The SoloVir ETS drives a large bolus of drug into the skin, breaking the barrier of the dermis and creating an intradermal drug depot in a single treatment.

[Process_of_Electrokinetic_Drug_Delivery.tif]
Image: The Process of Electrokinetic Drug Delivery
Caption: Electrokinetic drug delivery utilizes a low-voltage electric current to induce fluid and particle movement. Iontophoresis, a type of electrokinetic delivery, involves the application of an electromotive force to transport ions and neutral molecules through a solid or liquid medium, in this case the skin’s protective stratum corneum, and into the epidermis.

[Traditional_Dermal_Drug_Depot.tif]
Image: Traditional Topical Dermal Drug Treatment
Caption: In the conventional approach to dermal drug treatment, a topical drug slowly permeates the skin through passive diffusion. Arrow vectors represent movement of drug.

[SoloVir™_ETS_Dermal Drug Depot.tif]
Image: SoloVir™ ETS Dermal Drug Depot
Caption: Transports SoloVir ™ Electrokinetic Transdermal System (ETS) creates an intradermal drug depot with the first treatment. Transport’s ETS saturates the stratum corneum and epidermis with a drug in a single, 10-minute treatment. Arrow vectors represent movement and volume of drug.

[Self_Administration_with_Solovir.tif]
Image: (Woman self-administering with SoloVir™ ETS)
Caption: Transport’s Electrokinetic Transdermal System (ETS) consists of a reusable inotophoretic control unit and a disposable, unit-dose, single-use, pre-filled cartridge. The small, wireless control unit uses a low-voltage, which is varied in response to patient skin impedance to provide constant current and control of drug delivery. The drug delivery cartridge contains a unit dose of the proprietary drug formulation, as well as the drug delivery electrode. Portability of the battery-powered device allows patients to easily self-administer tropical drugs for a variety of indications.

[Herpes_Labialis_Life_Cycle.tif]
Image: Herpes Labialis Life Cycle
Caption: Cold sores have a distinct life cycle which can last 10-12 days. Day one is characterized by prodrome, a burning or tingling in the skin, which is an early indication of the onset of a herpetic episode. Prodromal symptoms occur in about 30 percent of herpes sufferers. The next stage is an erythema, a redness and bump in the skin, followed by papules, small conical elevations of the skin. These first stages are usually completed within the first 24 hours. A vesicle, or blister, appears the second day, which then breaks open to form an ulcer on day three. A soft/hard crust, the first sign of healing, appears on days three through eight, followed by a dry flaking and swelling of the skin on days eight through ten. The crust then falls off and the redness slowly subsides with a return to normal skin.

[Transport_Logo.tif]
Image: Transport Logo

back to top